Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Capital Work in Progress ₹428 Cr₹542 Cr₹419 Cr₹1,066 Cr₹921 Cr

What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS is ₹428 Cr based on Mar2026 Consolidated results.
Year Capital Work in Progress
Mar2026₹428 Cr
Mar2025₹542 Cr
Mar2024₹419 Cr
Mar2023₹1,066 Cr
Mar2022₹921 Cr

How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2026 ₹428 Cr
-21.05
Mar2025 ₹542 Cr
29.25
Mar2024 ₹419 Cr
-60.66
Mar2023 ₹1,066 Cr
15.71
Mar2022 ₹921 Cr -

Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹70,263.6 Cr 4% 11.5% 28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹469,310.0 Cr 2% -1.7% 15.9% Stock Analytics
DIVIS LABORATORIES ₹245,426.0 Cr 6.5% 14.8% 48.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,347.0 Cr 1.2% -2.5% 37.2% Stock Analytics
CIPLA ₹114,393.0 Cr -0.3% -3.9% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,240.2 Cr -2.2% 1.5% -8.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4%

11.5%

28.7%

SENSEX

-0.5%

-1.3%

-5.4%


You may also like the below Video Courses